Drug development and healthcare delivery, from discovery platforms through manufacturing to the companies involved.
61 articles
Synthetic immunology redesigns immune cells to enhance their disease-fighting capabilities and offers new promise for the treatment of diseases, such as cancer, by using simple...
Beckman Coulter Life Sciences is proud to present its newest product, the QbD1200+ Total Organic Carbon (TOC) Analyzer, boasting streamlined operations and strong data integrity....
Pharmaceutical companies around the world are rushing to manufacture and distribute a viable vaccine. There are five main approaches being taken to develop a vaccine...
Labcritics visited Xenopat, an innovative company dedicated to the orthotopic implantation of human tumors in mice. This technology allows Xenopat to offer services to companies...
Labcritics was at Iproteos’ facilities talking to Teresa Tarragó, CEO and co-founder of this innovative company. Iproteos combines computational chemistry with modern synthesis methods to generate...
Labcritics presents an interview with Jascha Blobel, CEO of Molomics, the first company that gamifies the drug discovery process. You will soon be able to...
Researchers from the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR in Singapore have developed a better technology to detect and treat infectious diseases and cancer....
The Food and Drug Administration (FDA) has approved Alexion’s Kanuma (sebelipase alfa), a compound for the treatment of the rare disease lysosomal acid lipase (LAL)...
